A new approach to measuring estrogen exposure and metabolism in epidemiologic studies

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 3-5, 2010, Pages 538-545

  Ziegler, R G ^a   Faupel Badger, J M ^a   Sue, L Y ^a   Fuhrman, B J ^a   Falk, R T ^a   Boyd Morin, J ^b   Henderson, M K ^a   Hoover, R N ^a   Veenstra, T D ^c   Keefer, L K ^d   Xu, X ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Estradiol; Estrogen metabolism; Estrone; Liquid chromatography tandem mass spectrometry

Indexed keywords

ESTRADIOL; ESTROGEN; ESTRONE; STABLE ISOTOPE;

ACCURACY; BREAST CANCER; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; EXPOSURE; GLUCURONIDATION; HORMONE DETERMINATION; HUMAN; LIQUID CHROMATOGRAPHY; OVARY CANCER; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN HYDROLYSIS; RADIOIMMUNOASSAY; REVIEW; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; EPIDEMIOLOGIC STUDIES; ESTROGENS; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 77955431592     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.068     Document Type: Review

References (33)

1. Key T., Appleby P., Barnes I., Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. 2002, 94(8):606-616.
2. Key T.J., Wang D.Y., Brown J.B., Hermon C., Allen D.S., Moore J.W., Bulbrook R.D., Fentiman I.S., Pike M.C. A prospective study of urinary oestrogen excretion and breast cancer risk. Br. J. Cancer 1996, 73(12):1615-1619.
3. Onland-Moret N.C., Kaaks R., van Noord P.A., Rinaldi S., Key T., Grobbee D.E., Peeters P.H. Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer. Br. J. Cancer 2003, 88(9):1394-1399.
4. Kaaks R., Berrino F., Key T., Rinaldi S., Dossus L., Biessy C., Secreto G., Amiano P., Bingham S., Boeing H., Bueno de Mesquita H.B., Chang-Claude J., Clavel-Chapelon F., Fournier A., van Gils C.H., Gonzalez C.A., Gurrea A.B., Critselis E., Khaw K.T., Krogh V., Lahmann P.H., Nagel G., Olsen A., Onland-Moret N.C., Overvad K., Palli D., Panico S., Peeters P., Quiros J.R., Roddam A., Thiebaut A., Tjonneland A., Chirlaque M.D., Trichopoulou A., Trichopoulos D., Tumino R., Vineis P., Norat T., Ferrari P., Slimani N., Riboli E. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J. Natl. Cancer Inst. 2005, 97(10):755-765.
5. Allen N.E., Key T.J., Dossus L., Rinaldi S., Cust A., Lukanova A., Peeters P.H., Onland-Moret N.C., Lahmann P.H., Berrino F., Panico S., Larranaga N., Pera G., Tormo M.J., Sanchez M.J., Ramon Quiros J., Ardanaz E., Tjonneland A., Olsen A., Chang-Claude J., Linseisen J., Schulz M., Boeing H., Lundin E., Palli D., Overvad K., Clavel-Chapelon F., Boutron-Ruault M.C., Bingham S., Khaw K.T., Bas Bueno-de-Mesquita H., Trichopoulou A., Trichopoulos D., Naska A., Tumino R., Riboli E., Kaaks R. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr. Relat. Cancer 2008, 15(2):485-497.
6. Eliassen A.H., Hankinson S.E. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv. Exp. Med. Biol. 2008, 630:148-165.
7. Yager J.D., Davidson N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 2006, 354(3):270-282.
8. Raftogianis R., Creveling C., Weinshilboum R., Weisz J. Estrogen metabolism by conjugation. J. Natl. Cancer Inst. Monogr. 2000, (27):113-124.
9. Jefcoate C.R., Liehr J.G., Santen R.J., Sutter T.R., Yager J.D., Yue W., Santner S.J., Tekmal R., Demers L., Pauley R., Naftolin F., Mor G., Berstein L. Tissue-specific synthesis and oxidative metabolism of estrogens. J. Natl. Cancer Inst. Monogr. 2000, (27):95-112.
10. Lee A.J., Cai M.X., Thomas P.E., Conney A.H., Zhu B.T. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology 2003, 144(8):3382-3398.
11. Zhu B.T. Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr. Drug Metab. 2002, 3(3):321-349.
12. Rogan E.G., Cavalieri E.L. Estrogen metabolites, conjugates, and DNA adducts: possible biomarkers for risk of breast, prostate, and other human cancers. Adv. Clin. Chem. 2004, 38:135-149.
13. Bradlow H.L., Telang N.T., Sepkovic D.W., Osborne M.P. 2-hydroxyestrone: the 'good' estrogen. J. Endocrinol. 1996, 150(Suppl):S259-S265.
14. Cavalieri E., Chakravarti D., Guttenplan J., Hart E., Ingle J., Jankowiak R., Muti P., Rogan E., Russo J., Santen R., Sutter T. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta 2006, 1766(1):63-78.
15. Xu X., Roman J.M., Issaq H.J., Keefer L.K., Veenstra T.D., Ziegler R.G. Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal. Chem. 2007, 79(20):7813-7821.
16. Xu X., Veenstra T.D., Fox S.D., Roman J.M., Issaq H.J., Falk R., Saavedra J.E., Keefer L.K., Ziegler R.G. Measuring 15 endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal. Chem. 2005, 77(20):6646-6654.
17. Stanczyk F.Z., Lee J.S., Santen R.J. Standardization of steroid hormone assays: why, how, and when?. Cancer Epidemiol. Biomarkers Prev. 2007, 16(9):1713-1719.
18. Falk R.T., Xu X., Keefer L., Veenstra T.D., Ziegler R.G. A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol. Biomarkers Prev. 2008, 17(12):3411-3418.
19. Eliassen A.H., Ziegler R.G., Rosner B., Veenstra T.D., Roman J.M., Xu X., Hankinson S.E. Reproducibility of 15 urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol. Biomarkers Prev. 2009, 18(11):2860-2868.
20. B.J. Fuhrman, X. Xu, R.T. Falk, S.E. Hankinson, T.D. Veenstra, L.K. Keefer, R.G. Ziegler, Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies, submitted for publication.
21. Adlercreutz H., Kiuru P., Rasku S., Wahala K., Fotsis T. An isotope dilution gas chromatographic-mass spectrometric method for the simultaneous assay of estrogens and phytoestrogens in urine. J. Steroid Biochem. Mol. Biol. 2004, 92(5):399-411.
22. Fotsis T., Jarvenpaa P., Adlercreutz H. Purification of urine for quantification of the complete estrogen profile. J. Steroid Biochem. 1980, 12:503-508.
23. Tworoger S.S., Hankinson S.E. Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer Epidemiol. Biomarkers Prev. 2006, 15(9):1578-1581.
24. Lee J.S., Ettinger B., Stanczyk F.Z., Vittinghoff E., Hanes V., Cauley J.A., Chandler W., Settlage J., Beattie M.S., Folkerd E., Dowsett M., Grady D., Cummings S.R. Comparison of methods to measure low serum estradiol levels in postmenopausal women. J. Clin. Endocrinol. Metab. 2006, 91(10):3791-3797.
25. Santen R.J., Demers L., Ohorodnik S., Settlage J., Langecker P., Blanchett D., Goss P.E., Wang S. Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy. Steroids 2007, 72(8):666-671.
26. 2 in pediatric endocrinology. Mol. Cell Endocrinol. 2009, 301(1-2):272-281.
27. Pasqualini J.R., Chetrite G.S. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J. Steroid Biochem. Mol. Biol. 2005, 93(2-5):221-236.
28. Zhu B.T., Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998, 19(1):1-27.
29. Ziegler R.G., Hoover R.N., Pike M.C., Hildesheim A., Nomura A.M., West D.W., Wu-Williams A.H., Kolonel L.N., Horn-Ross P.L., Rosenthal J.F., Hyer M.B. Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst. 1993, 85(22):1819-1827.
30. Falk R.T., Gail M.H., Fears T.R., Rossi S.C., Stanczyk F., Adlercreutz H., Kiura P., Wahala K., Donaldson J.L., Vaught J.B., Fillmore C.M., Hoover R.N., Ziegler R.G. Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre- and postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 1999, 8(6):567-577.
31. Falk R.T., Fears T.R., Xu X., Hoover R.N., Pike M.C., Wu A.H., Nomura A.M., Kolonel L.N., West D.W., Sepkovic D.W., Bradlow H.L., Ziegler R.G. Urinary estrogen metabolites and their ratio among Asian-American women. Cancer Epidemiol. Biomarkers Prev. 2005, 14(1):221-226.
32. Falk R.T., Rossi S.C., Fears T.R., Sepkovic D.W., Migella A., Adlercreutz H., Donaldson J., Bradlow H.L., Ziegler R.G. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid. Cancer Epidemiol. Biomarkers Prev. 2000, 9(1):81-87.
33. Faupel-Badger J.M., Fuhrman B.J., Xu X., Falk R.T., Keefer L.K., Veenstra T.D., Hoover R.N., Ziegler R.G. Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens. Cancer Epidemiol. Biomarkers Prev. 2010, 19(1):292-300.